ArticleNature communications2021

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.

Eric J Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.